Briviact 50 mg/5 ml, solution injectable
7680658300016
CH-65830
Injektionslösung
Associated product:
BRIVIACT sol inj 50 mg/5ml 10 flac 5 ml
1 / 3
google
Article details
- Package size
- 10
- Selling units
- 10
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
19.0875 MG | Substance | HBESI |
Authorization holder
UCB-Pharma SA
1630 Bulle
Authorization information
- Swissmedic authorization number
- 65830
- Drug name
- Briviact, solution injectable
- Galenic form
- LSPA
- ATC Code
- N03AX23
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 06/10/2016
- Authorization expiration date
- 31/12/9999
- IT Number
- 01.07.1.
- Domain
- Human medicine
Package details
- Description (FR)
- BRIVIACT sol inj 50 mg/5ml 10 flac 5 ml
- Description (DE)
- BRIVIACT Inj Lös 50 mg/5ml 10 Durchstf 5 ml
- Market launch
- 06/10/2016
- Narcotic (BTM)
- No
Other package sizes (1)
None
10 DUR
GTIN: None